Depomed stock price

Depomed (NYSE:ASRT) Stock Price Up 5.6% - Redmond Register Apr 07, 2020 · Depomed, Inc. (NYSE:ASRT) shares rose 5.6% on Monday . The stock traded as high as $0.68 and last traded at $0.67, approximately 611,680 shares changed hands during mid-day trading. A decline of 67% from the average daily volume of 1,853,356 shares. The stock had previously closed at $0.63. Separately, Zacks Investment Research lowered Depomed from […]

Stock Quote | Assertio Therapeutics, Inc. The Investor Relations website contains information about Assertio Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. ASRT | Assertio Therapeutics Inc. Profile | MarketWatch Nov 05, 2019 · DepoMed stock price target raised to $8 from $6 at UBS. 10:24 a.m. Dec. 7, 2017 - Tomi Kilgore. Barron’s After Hours: Collegium Jumps, Ascena Retail Slumps, Cleveland-Cliffs Falls. ASRT - Stock quote for ASSERTIO THERAPEUTICS, INC. - MSN … View the latest ASRT stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ASSERTIO THERAPEUTICS, INC.. Depomed: Can Starboard Turn A Lemon Into Lemonade ...

At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. ASRT Stock | DEPOMED Stock Price Today | Markets Insider ASRT: Get the latest Depomed stock price and detailed information including ASRT news, historical charts and realtime prices. ASRT Stock Price | Assertio Therapeutics Inc. Stock Quote ... View real-time stock prices and stock quotes for a full financial overview. DepoMed stock price target raised to $8 from $6 at UBS. Dec. 7, 2017 at 9:25 a.m. ET by Tomi Kilgore. DEPO Stock Quote - Assertio Therapeutics Inc - Bloomberg ... Stock analysis for Assertio Therapeutics Inc (DEPO) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

View real-time stock prices and stock quotes for a full financial overview. DepoMed stock price target raised to $8 from $6 at UBS. Dec. 7, 2017 at 9:25 a.m. ET by Tomi Kilgore.

Analyzing Depomed (NASDAQ:DEPO) stock? View DEPO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. DEPO - TheStreet Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER. By Melissa Angell. Stock futures rise ahead of first trading day of 2017. By Keris Alison Lahiff. Jan 3, 2017 8:42 AM EST. ASRT Stock Price, Forecast & News (Depomed) | MarketBeat 1 Wall Street analysts have issued 1-year price targets for Depomed's stock. Their forecasts range from $3.00 to $3.00. On average, they expect Depomed's share price to reach $3.00 in the next twelve months. This suggests a possible upside of 372.7% from the stock's …

Combined Company Pro Forma 2019 Net Product Sales of Approximately $128 Million 1 Expects to Capture Significant Operating and Product Portfolio Synergies Upwards of $40 Million , Accelerating Revenue Growth and Creating Shareholder Value Arthur Higgins to …

Check out our DEPO stock analysis, current DEPO quote, charts, and historical prices for Depomed Inc stock

Depomed, Inc. (NYSE:ASRT) shares dropped 7.9% during trading on Monday . The stock traded as low as $1.23 and last traded at $1.28, approximately 2,961,100 shares changed hands during mid-day trading.

We are Assertio — an assertive, energetic, and empathetic pharmaceutical company built around the mission of advancing patient care. Formerly known as Depomed, we have transformed our company with a current focus on three FDA-approved products in our core areas of neurology, orphan, and specialty medicines, as we continue to identify, license, and develop new products that offer enhanced DEPO interactive stock chart | Depomed, Inc. stock - Yahoo ... At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life. NASDAQ:DEPO Depomed, Inc. Stock Analysis - CapitalCube Summary quote, performance, and fundamental analysis for NASDAQ:DEPO Depomed, Inc.

Get breaking news and analysis on Assertio Therapeutics, Inc. (ASRT) stock, price quote and chart, trading and investing tools. Sign in Don't Buy The Depomed Buyout Rumors; Buy The Certainty Depomed | DEPO - Stock Price | Live Quote | Historical Chart Depomed stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. Depomed - Overview | Assertio Therapeutics, Inc. Combined Company Pro Forma 2019 Net Product Sales of Approximately $128 Million 1 Expects to Capture Significant Operating and Product Portfolio Synergies Upwards of $40 Million , Accelerating Revenue Growth and Creating Shareholder Value Arthur Higgins to …